We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+11.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$7.81B
AUM Growth
+$540M
(+7.4%)
Cap. Flow
-$59.7M
Cap. Flow
% of AUM
-0.76%
Top 10 Holdings %
Top 10 Hldgs %
4.74%
Holding
3,067
New
528
Increased
1,137
Reduced
1,133
Closed
263
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$48.4M |
| 2 |
Apple
AAPL
|
+$40.9M |
| 3 |
PayPal
PYPL
|
+$33.6M |
| 4 |
Chubb
CB
|
+$30.7M |
| 5 |
Illumina
ILMN
|
+$28.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$36M |
| 2 |
Lockheed Martin
LMT
|
+$31.4M |
| 3 |
CDW
CDW
|
+$31.3M |
| 4 |
D.R. Horton
DHI
|
+$27.4M |
| 5 |
Fidelity National Information Services
FIS
|
+$27.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.29% |
| 2 | Consumer Discretionary | 15.76% |
| 3 | Healthcare | 14% |
| 4 | Financials | 13.56% |
| 5 | Industrials | 11.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
TSMC
TSM
$2.19T
| $57K | ﹤0.01% |
486
-14,205
| -97% | -$1.76M |
|
|
ACCD
2727
DELISTED
Accolade Inc
ACCD
| $57K | ﹤0.01% |
+1,249
| New | +$60.1K |
|
|
LONA
2728
LeonaBio Inc
LONA
$72M
| $56K | ﹤0.01% |
+303
| New | +$66.8K |
|
2729
BGC Group
BGC
$4.91B
| $52K | ﹤0.01% |
10,723
-41,417
| -79% | -$176K |
|
|
NGD
2730
DELISTED
New Gold Inc
NGD
| $52K | ﹤0.01% |
33,728
-291,990
| -90% | -$528K |
|
|
CASI
2731
DELISTED
CASI Pharmaceuticals
CASI
| $51K | ﹤0.01% |
2,110
+717
| +51% | +$20.1K |
|
|
CLSD
2732
DELISTED
Clearside Biomedical
CLSD
| $51K | ﹤0.01% |
+1,373
| New | +$68.9K |
|
2733
Minerva Neurosciences
NERV
$201M
| $51K | ﹤0.01% |
2,200
+725
| +49% | +$18.1K |
|
2734
Aurinia Pharmaceuticals
AUPH
$2.06B
| $50K | ﹤0.01% |
3,889
+2,033
| +110% | +$29.5K |
|
|
NMTR
2735
DELISTED
9 Meters Biopharma
NMTR
| $50K | ﹤0.01% |
+2,135
| New | +$65.6K |
|
|
CIT
2736
DELISTED
CIT Group Inc.
CIT
| $50K | ﹤0.01% |
971
-4,074
| -81% | -$183K |
|
2737
Brookfield Renewable
BEP
$9.87B
| $48K | ﹤0.01% |
1,118
-6,246
| -85% | -$277K |
|
|
SOLO
2738
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
| $48K | ﹤0.01% |
+10,235
| New | +$69.5K |
|
|
APLT
2739
DELISTED
Applied Therapeutics
APLT
| $47K | ﹤0.01% |
2,510
-7,249
| -74% | -$156K |
|
2740
Fulcrum Therapeutics
FULC
$288M
| $43K | ﹤0.01% |
3,655
+3,110
| +571% | +$38.5K |
|
2741
Banco Santander
SAN
$210B
| $43K | ﹤0.01% |
12,680
-478
| -4% | -$1.62K |
|
|
BCLI
2742
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $42K | ﹤0.01% |
+733
| New | +$55.4K |
|
2743
Enel Chile
ENIC
$6.22B
| $41K | ﹤0.01% |
10,355
-6,511
| -39% | -$25.7K |
|
2744
Fortress Biotech
FBIO
$88.7M
| $41K | ﹤0.01% |
+778
| New | +$43.9K |
|
2745
Matinas BioPharma
MTNB
$1.74M
| $39K | ﹤0.01% |
+744
| New | +$49.9K |
|
|
KIN
2746
DELISTED
Kindred Biosciences, Inc.
KIN
| $39K | ﹤0.01% |
+7,903
| New | +$38.2K |
|
2747
Ascendis Pharma A/S
ASND
$16.6B
| $38K | ﹤0.01% |
291
-590
| -67% | -$89.7K |
|
|
CHX
2748
DELISTED
ChampionX
CHX
| $38K | ﹤0.01% |
1,744
-25,092
| -94% | -$488K |
|
2749
Seanergy Maritime Holdings
SHIP
$357M
| $38K | ﹤0.01% |
+3,580
| New | +$41K |
|
|
TELL
2750
DELISTED
Tellurian Inc.
TELL
| $38K | ﹤0.01% |
16,171
| – | – |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q1 2021 Portfolio in Review
As of Q1 2021, Cubist Systematic Strategies held 3,067 positions worth $7.81B, up 7.4% from $7.27B the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.
Cubist Systematic Strategies's Q1 2021 filing shows 528 new, 1,137 increased, 1,133 reduced and 263 closed positions. Its largest new stake was PhenomeX Inc. Common Stock: 210,710 shares worth $10.6M. The largest sale was Danaher, an estimated $36M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Cubist Systematic Strategies's largest Q1 2021 buy was PhenomeX Inc. Common Stock: 210,710 shares worth $10.6M.
- Cubist Systematic Strategies added most to Aptiv in Q1 2021, an estimated $48.4M increase.
- Cubist Systematic Strategies's biggest Q1 2021 reduction was Danaher, cutting an estimated $36M.
- Cubist Systematic Strategies fully exited American Tower in Q1 2021, selling an estimated $19.5M.
- Cubist Systematic Strategies's ten largest holdings make up 4.7% of its $7.81B portfolio in Q1 2021.
- Cubist Systematic Strategies opened 528 new positions and closed 263 in Q1 2021.
- Cubist Systematic Strategies's portfolio value rose 7.4% quarter-over-quarter to $7.81B.
Based on Cubist Systematic Strategies's 13F filing for Q1 2021, filed 17 May 2021.